减轻与心肺旁路相关的不适应性炎症反应的策略
Debolina Banerjee1, Jun Feng1, Frank W Sellke1
1Division of Cardiothoracic Surgery, Department of Surgery, Brown University/Rhode Island Hospital, Providence, RI, United States.
Frontiers in surgery
|July 18, 2024
概括
心肺绕道 (CPB) 引发显著的炎症,可能导致并发症. 减少这种炎症反应的策略,包括电路修改和药物,旨在改善患者的治疗结果.
科学领域:
- 心血管外科心血管外科
- 免疫学 免疫学 免疫学
- 生物医学工程 生物医学工程
背景情况:
- 心肺绕道 (CPB) 与显著的炎症反应有关.
- 导致炎症的因素包括血流变化,低温,手术创伤和与体外电路接触.
- 无法控制的炎症可能导致严重的术后并发症.
研究的目的:
- 审查CPB期间的炎症反应.
- 讨论技术和药理学策略,以减轻这种反应.
- 突出多式联络方法对于改善临床结果的重要性.
主要方法:
- 对CPB诱导的炎症现有研究的审查.
- 对体外电路的技术修改进行分析.
- 对针对炎症途径的药理干预措施的评估.
主要成果:
- CPB激活了多个炎症和凝血级联.
- 诸如生物相容表面和微型电路等技术改进显示出有前途.
- 药物学辅助剂,如阿波丁,类固醇和自由基清除剂正在接受调查.
结论:
- 结合技术和药理干预的综合战略至关重要.
- 在CPB期间减轻炎症反应可以导致更好的患者结果.
- 需要进一步的研究来优化这些多式联运方式的方法.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
418
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
418
Inflammatory Response
1.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.9K
Acute Respiratory Failure-V
129
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
129
Drugs Used in Lower Respiratory Disorders: Overview
390
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
390
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K


